Patents by Inventor J. Michael Cherry

J. Michael Cherry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and System for the Use of Biomarkers for Regulatory Dysfunction in Disease
    Publication number: 20180373838
    Abstract: Measuring of the binding of a transcription factor (using, for example, chromatin immunoprecipitation) according to the present invention is provides an improved marker for a disease. These markers can be used in diagnostics for diseases where a transcription factor binding event plays a role. Additionally, they can be used to adjust disease risk profiles for healthy individuals as with typical genetic variants.
    Type: Application
    Filed: April 16, 2018
    Publication date: December 27, 2018
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Konrad Karczewski, Michael Snyder, Atul J. Butte, Joel T. Dudley, Eurie Hong, Alan Boyle, J. Michael Cherry, Julie Park
  • Method and system for the use of biomarkers for regulatory dysfunction in disease
    Patent number: 9946835
    Abstract: Measuring of the binding of a transcription factor (using, for example, chromatin immunoprecipitation) according to the present invention is provides an improved marker for a disease. These markers can be used in diagnostics for diseases where a transcription factor binding event plays a role. Additionally, they can be used to adjust disease risk profiles for healthy individuals as with typical genetic variants.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: April 17, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Konrad Karczewski, Michael Snyder, Atul Butte, Joel T. Dudley, Eurie Hong, Alan Boyle, J. Michael Cherry, Julie Park
  • Method and System for the Use of Biomarkers for Regulatory Dysfunction in Disease
    Publication number: 20130116931
    Abstract: Measuring of the binding of a transcription factor (using, for example, chromatin immunoprecipitation) according to the present invention is provides an improved marker for a disease. These markers can be used in diagnostics for diseases where a transcription factor binding event plays a role. Additionally, they can be used to adjust disease risk profiles for healthy individuals as with typical genetic variants.
    Type: Application
    Filed: August 22, 2012
    Publication date: May 9, 2013
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Konrad Karczewski, Michael Snyder, Atul J. Butte, Joel T. Dudley, Eurie Hong, Alan Boyle, J. Michael Cherry